Location of Repository

Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study

By Sonia Nava-Salazar, Elly N Sánchez-Rodríguez, C Adriana Mendoza-Rodríguez, Carlos Moran, Juan F Romero-Arauz and Marco A Cerbón
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3076269
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2005). Acosta A: Maternal near miss and maternal death in the World Health Organization’s
    2. (2009). Alavez G: Epidemiología, clasificación y factores de riesgo en preeclampsia.
    3. (2007). Assimes TL, Tibshirani RJ, Go AS: Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J
    4. (2002). Bulletin: Diagnosis and management of preeclampsia and eclampsia. Number 33. American College of Obstetricians and Gynecologists. Obstet Gynecol
    5. (2004). Chayama K: Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep
    6. (2006). D’Amato RJ: The effect of genetic diversity on angiogenesis. Exp Cell Res
    7. (2005). Ding XF: Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis
    8. (2009). Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia– a step forward but not the definitive answer. J Reprod Immunol
    9. (2008). Ekmekci A: Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF1alpha) gene in human sporadic breast cancer. Arch Med Res
    10. (2010). Elovitz MA: Allelic variations in angiogenic pathway genes are associated with preeclampsia.
    11. (2002). Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways.
    12. (2001). ER: The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene
    13. (2000). Expression, ontogeny, and regulation of hypoxiainducible transcription factors in the human placenta. Biol Reprod
    14. (2005). Genetic variation in the HIF-1α gene is associated with type 2 diabetes in Japanese.
    15. (1992). GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol
    16. (2002). Hypoxia inducible factor-1: Oxygen regulation of trophoblast differentiation in normal and pre-eclamptic Pregnancies - A Review. Placenta
    17. (2003). Hypoxia-inducible factor-1a polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis
    18. (2006). Hypoxia-inducible factor-1α polymorphisms and TSC1/2 mutations are complementary in head and neck cancers. Mol Cancer
    19. (1999). Kafury-Goeta AC: Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review.
    20. (2000). Khaliq A: Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen-a review. Placenta
    21. (2008). KS: The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol Rep
    22. (2010). Lancet
    23. (2007). Lineamiento Técnico: Prevención, diagnóstico y manejo de la preeclampsia/eclampsia.
    24. (2004). Maltezos E: Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod
    25. (2001). Markovic N: Selective overexpression of the hypoxia-inducible transcription factor, HIF-2a, in placentas from women with preeclampsia. Biol Reprod
    26. (2006). Navarrete HE: Mortalidad materna en el IMSS, 1991-2005. Un periodo de cambios. Rev Med Inst Mex Seguro Soc
    27. (2008). Non-synonymous sequence variants within the oxygen-dependent degradation domain of the HIF1A gene are not associated with pre-eclampsia in the Finnish population.
    28. (2000). Oxigen and placental development during the first trimester: Implications for the patophysiology of preeclampsia. Placenta
    29. (2008). Preeclampsia and angiogenic imbalance. Annu Rev Med
    30. (2005). Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ
    31. (2004). SA: Circulating angiogenic factors and the risk of preeclampsia.
    32. (2010). Salihu HM: Super-obesity and risk for early and late pre-eclampsia. BJOG
    33. (1997). SJ: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?
    34. (2005). SP: Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.